Glenn L.Krinsky


Los Angeles +

Glenn Krinsky advises academic medical centers and major nonprofit hospital systems in California, throughout the United States, and internationally with their regulatory, transactional, operational, and investigatory affairs. Glenn's experience encompasses the full spectrum of health care delivery system and biomedical research enterprise issues, including academic affiliations, corporate governance, technology transfer, and national and international clinical trial research collaborations. He is also one of Jones Day's stateside leaders of its Middle East health care practice.

Glenn has further established himself as the nation's foremost practitioner in the representation of organ transplant programs, having represented 37 such programs in 23 states and the District of Columbia over the past two decades. These representations include complex proceedings in federal courts and before the United Network for Organ Sharing (UNOS) and the Centers for Medicare and Medicaid Services (CMS).

Prior to joining Jones Day, Glenn served as chief legal officer and executive vice president of City of Hope National Medical Center and Beckman Research Institute in Duarte, California, an NCI-designated Comprehensive Cancer Center. He was responsible for all legal issues, as well as matters concerning corporate governance, crisis management, and federal lobbying activities. Glenn supervised City of Hope's 2002 trial against biotechnology industry leader Genentech, which resulted in a jury verdict in excess of $300 million in compensatory damages, a verdict upheld by both the California Court of Appeal and the California Supreme Court. He also successfully defended City of Hope in a comprehensive investigation conducted by the California Attorney General's Office, which resulted in a "no-action" letter, and successfully negotiated with major media organizations, including the CBS News program "60 Minutes" and the Los Angeles Times, regarding coverage of the issues presented in the attorney general's investigation.


  • Large critical infrastructure employer considers implementing COVID-19 testing program for employeesJones Day represented a large critical infrastructure employer during the COVID-19 crisis to consider and assess appropriate protocols and policies for implementing an employee COVID-19 testing program at its sites. This included counseling on myriad federal, state, and local legal and regulatory frameworks as well as forming appropriate partnerships.
  • Luxury department store chain develops employee programming to mitigate spread of COVID-19 within workplaceJones Day represented a luxury department store chain during the COVID-19 crisis to develop appropriate protocols and policies for implementing an employee temperature screening program, a face covering program, work from home and return to work policies for employees suffering from COVID-19, respiratory illness, or exposure to individuals with COVID-19.
  • U.S. healthcare company arbitrates ICC claim against Middle Eastern hospital proprietorJones Day is representing a Pittsburgh-based international healthcare management and consulting company in an ICC commercial arbitration against an owner of medical centers and clinics in the Middle East.
  • St. Jude and Juno secure $12.25 million settlement resolving patent dispute with Novartis Pharmaceuticals and University of PennsylvaniaJones Day represented St. Jude Children's Research Hospital ("St. Jude") in enforcing breach of contract claims and defending patent invalidity claims against the University of Pennsylvania ("Penn") and Novartis Pharmaceuticals ("Novartis").
  • Hoag Memorial Hospital forms regional health systemJones Day assisted Hoag Memorial Hospital Presbyterian in its affiliation with St. Joseph Health to form an integrated regional health system.
  • City of Hope forms City of Hope Medical FoundationJones Day advised the City of Hope in connection with the development and formation of City of Hope Medical Foundation (COHMF) and the purchase by COHMF of California Cancer Specialists Medical Group (CCSMG) and Oncology Specialists of COH (OSCOH).
  • High Road Capital acquires Advanced Sleep Medicine ServicesJones Day advised High Road Capital Partners in connection with its acquisition and related financing of Advanced Sleep Medicine Services, Inc., a leading provider of sleep diagnostic services and sleep-related Durable Medical Equipment (DME) in Southern California.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.